Tyra Biosciences (TYRA) Non-Current Assets (2020 - 2026)
Quarterly Non-Current Assets fell 7.84% to $17.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $74.6 million through Mar 2026, up 16.74% year-over-year, with the annual reading at $17.2 million for FY2025, 6.61% up from the prior year.
Tyra Biosciences filings provide 7 years of Non-Current Assets readings, the most recent being $17.4 million for Q1 2026.
- Non-Current Assets hit $17.4 million in Q1 2026 for Tyra Biosciences, up from $17.2 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $20.6 million in Q3 2025 and bottomed at $4.9 million in Q1 2022.
- Average Non-Current Assets over 5 years is $13.5 million, with a median of $14.0 million recorded in 2024.
- The largest annual shift saw Non-Current Assets skyrocketed 244.84% in 2022 before it decreased 7.84% in 2026.
- Tyra Biosciences' Non-Current Assets stood at $8.9 million in 2022, then surged by 59.52% to $14.2 million in 2023, then rose by 13.46% to $16.1 million in 2024, then increased by 6.61% to $17.2 million in 2025, then grew by 1.56% to $17.4 million in 2026.
- Per Business Quant, the three most recent readings for TYRA's Non-Current Assets are $17.4 million (Q1 2026), $17.2 million (Q4 2025), and $20.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 4.56 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 62,953.78 |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 486.60 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 5.83 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 30.30 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 14.75 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 22.66 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 910.24 Mn |
| 10 | Tyra Biosciences | 2.03 Bn | 2.03 Bn | - | 17.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.43 Mn |
| Dec 31, 2025 | 17.16 Mn |
| Sep 30, 2025 | 20.64 Mn |
| Jun 30, 2025 | 19.34 Mn |
| Mar 31, 2025 | 18.91 Mn |
| Dec 31, 2024 | 16.10 Mn |
| Sep 30, 2024 | 14.98 Mn |
| Jun 30, 2024 | 13.89 Mn |
| Mar 31, 2024 | 13.96 Mn |
| Dec 31, 2023 | 14.19 Mn |
| Sep 30, 2023 | 13.73 Mn |
| Jun 30, 2023 | 9.27 Mn |
| Mar 31, 2023 | 8.35 Mn |
| Dec 31, 2022 | 8.89 Mn |
| Sep 30, 2022 | 8.51 Mn |
| Jun 30, 2022 | 9.82 Mn |
| Mar 31, 2022 | 4.95 Mn |
| Dec 31, 2021 | 2.64 Mn |
| Sep 30, 2021 | 2.47 Mn |
| Dec 31, 2020 | 730,000.00 |